Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease

Guselkumab for hidradenitis suppurativa in a patient with concomitant Crohn's disease: Report and systematic literature review of effectiveness and safety

Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt

Præsentation
Citationsformater

Dokumenter

Guselkumab for hidradenitis suppurativa in a patient with concomitant
Forlagets udgivne version, 451 KB, PDF-dokument

Astrid-Helene Ravn Jorgensen
Jesper Grønlund Holm
Thomsen, Simon Francis

Guselkumab appears to be safe and effective in the treatment of patients with HS, who do not respond to adalimumab and other systemic therapies. Guselkumab can be used in patients with comorbid Crohn's disease.

Originalsprog	Engelsk
Tidsskrift	Clinical Case Reports
Vol/bind	8
Udgave nummer	12
Sider (fra-til)	2874-2877
Antal sider	4
ISSN	2050-0904
DOI	https://doi.org/10.1002/ccr3.3090
Status	Udgivet - 2020

Antal downloads er baseret på statistik fra Google Scholar og www.ku.dk

Ingen data tilgængelig

ID: 249860508